Quantedge Capital Pte LTD Intercept Pharmaceuticals, Inc. Transaction History

Quantedge Capital Pte LTD

  • $328 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
SELL
$12.21 - $19.7 $1.17 Million - $1.9 Million
-96,200 Reduced 33.22%
193,400 $2.7 Million
Q2 2022

Aug 12, 2022
BUY
$11.23 - $19.59 $2.77 Million - $4.83 Million
246,800 Added 576.64%
289,600 $4 Million
Q1 2022

May 13, 2022
BUY
$13.37 - $17.79 $572,236 - $761,412
42,800 New
42,800 $696,000

Others Institutions Holding ICPT

# of Institutions
6
Shares Held
1.04M
Call Options Held
30K
Put Options Held
5.9K
View Full List

About INTERCEPT PHARMACEUTICALS, INC.

ICPT Quotes by TradingView
  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Quantedge Capital Pte LTD Portfolio

Follow Quantedge Capital Pte LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantedge Capital Pte LTD, based on Form 13F filings with the SEC.

News

Stay updated on Quantedge Capital Pte LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email